Discover 2,262 paid clinical trials in San Francisco, California. Search by condition or phase to find a research study near you that matches your needs across various therapeutic areas.
San Francisco offers opportunities for individuals interested in taking part in paid studies as healthy volunteers, as well as those looking for studies for a specific medical condition. The city has a strong emphasis on cutting-edge research for conditions such as HIV/AIDS, oncology, kidney disease, PCOS, and endometriosis, among others. By participating, you can gain access to the latest healthcare innovations and contribute to pioneering medical progress.
Filter
2
Filter results
Results: 2,262
Nerve Transfer to Improve Function in High Level Tetraplegia
for
Cervical Spinal Cord Injury, Tetraplegia
Location: Stanford CA, Salt Lake City UT, Houston TX, St Louis MO,
Sponsor: Washington University School of Medicine
Sex: All
Age: 18 - 70+
Code: NCT06288763
Recruiting
Serial Circulating Tumor DNA (ctDNA) Monitoring During Adjuvant Capecitabine in Early Triple-negative Breast Cancer
for
Triple Negative Breast Cancer, Breast Cancer
Location: Stanford CA
Sponsor: Stanford University
Sex: All
Age: 18+
Code: NCT04768426
Phase 2, Recruiting
Generative AI Plan for Care Lab Study
for
Primary Health Care
Location: Mountain View CA
Sponsor: Fitbit LLC
Sex: All
Age: 18+
Code: NCT07552311
Recruiting
Medical Residents Learning Weight Management Counseling Skills
for
Weight Management Counseling
Location: Palo Alto CA, Sacramento CA, Houston TX, Hershey PA,
Sponsor: University of Massachusetts, Worcester
Sex: All
Age: 18+
Code: NCT06529666
Recruiting
A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo
for
Vitiligo, Non-Segmental Vitiligo (NSV)
Location: Fremont CA, Oxnard CA, Santa Clarita CA, Northridge CA,
Sponsor: Eli Lilly and Company
Sex: All
Age: 18 - 70+
Code: NCT07533019
Phase 2, Recruiting
Interested in new trials?
Get alerts for new trials in your area by subscribing now
A Multi-Institution Study of TGFβ Imprinted, Ex Vivo Expanded Universal Donor NK Cell Infusions as Adoptive Immunotherapy in Combination With Gemcitabine and Docetaxel in Patients With Relapsed or Refractory Pediatric Bone and Soft Tissue